⏳ Fetching live dividend data...
Home › Calculator › MRVFF Dividend Calculator 2026
Nuvo Pharmaceuticals Inc. · OTC
Price: $0.98 · Annual div: None · Frequency: — · Payout ratio: N/A · Ex-div: —
MRVFF is not a dividend-focused stock
MRVFF pays a very low or no dividend (Yield: 0.00%). This calculator is designed for income-producing assets. If your goal is passive income and compounding, you might want to look at these popular alternatives:
Nuvo Pharmaceuticals Inc. (MRVFF) does not currently pay a regular dividend in our data, so its dividend yield is 0%.
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
Nuvo Pharmaceuticals Inc., which operates globally under the trade name Miravo Healthcare, specializes in delivering both prescription and over-the-counter medical products. The company's diverse portfolio addresses key therapeutic areas, including pain management, allergy relief, neurological conditions, and dermatological concerns. Its operations are structured into three distinct business units: a Commercial division, a Production and Service division, and a Licensing and Royalty division. Among its significant offerings are Blexten, an antihistamine prescribed for the symptomatic treatment of allergic rhinitis and chronic spontaneous urticaria; Cambia, a nonsteroidal anti-inflammatory drug for migraine episodes; and Suvexx/Treximet, another medication for migraine. Nuvo also provides NeoVisc, an injectable viscosupplement utilized in managing osteoarthritis, alongside treatments for head lice infestations such as Resultz, FullMarks, and LAUSBUB. For metabolic health, the company supplies Bezalip SR, aimed at patients with elevated cholesterol or triglyceride levels, and Proferrin, an iron supplement for the prevention and treatment of iron deficiency. Their pain relief options include Fiorinal 1 and Fiorinal C1 for tension-type headaches, and Collatamp G, designed for surgical implantation during operations. Nuvo's gastrointestinal product line features PegaLAX, a laxative for occasional constipation; Mutaflor, a probiotic to manage chronic constipation, abdominal pain, and cramps; and MoviPrep, used for bowel cleansing in preparation for colonoscopies. Soriatane is available for the treatment of psoriasis and other keratinization disorders. Additionally, their range of topical solutions includes Pennsaid and Pennsaid 2% for osteoarthritic pain; Vimovo, which alleviates arthritis symptoms; SYNERA and RAPYDAN topical patches, employed to mitigate pain during needle sticks and other superficial skin procedures; and the Heated Lidocaine/Tetracaine Patch, applied prior to painful medical interventions. Yosprala is also part of their portfolio, focused on preventing heart attacks and strokes. The company was originally incorporated in 1983 and was formerly known as Nuvo Research Inc. It officially adopted the name Nuvo Pharmaceuticals Inc. in March 2016 and maintains its corporate headquarters in Mississauga, Canada.
No. Nuvo Pharmaceuticals Inc. (MRVFF) has not paid a regular dividend in the last 12 months in our data, so its dividend yield is 0% and it produces no dividend income.
Dividend ETFs such as SCHD, VYM or JEPI pay regular income. Open their DRIP calculators to see what $10,000 would earn per month and how reinvesting grows it.
A DRIP reinvests dividends into new shares. MRVFF has no regular dividend in our data, so there is nothing to reinvest.
Forward dividend yield from the latest data · open any DRIP calculator
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open MRVFF position with:
Real after-tax yield depends on where you live and how you hold MRVFF.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 0.00% | -2.80% | $0 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 0.00% | -2.80% | $0 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 0.00% | -2.80% | $0 / yr |
| 🇬🇧 UK ISA | 0% | 0.00% | -2.80% | $0 / yr |
| 🇬🇧 UK Taxable | 8.75% | 0.00% | -2.80% | $0 / yr |
| 🇨🇦 TFSA | 0% | 0.00% | -2.80% | $0 / yr |
| 🇨🇦 CA Taxable | 25% | 0.00% | -2.80% | $0 / yr |
| 🇦🇺 Super (pension) | 15% | 0.00% | -2.80% | $0 / yr |
| 🇦🇺 AU Taxable | 30% | 0.00% | -2.80% | $0 / yr |
| 🇩🇪 DE Taxable | 26.375% | 0.00% | -2.80% | $0 / yr |
| 🇫🇷 FR Taxable | 30% | 0.00% | -2.80% | $0 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
No dividend data available for this ticker.
Based on current dividend of $0.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
MRVFF pays quarterly — 4 times per year. Ex-div: —.
How MRVFF compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for MRVFF sourced from FMP /financial-growth endpoint — real data, not estimates.
Compare MRVFF with peers: MRVFF vs ATBPF · MRVFF vs CNPOF · MRVFF vs FLWPF
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the MRVFF dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Nuvo Pharmaceuticals Inc. (MRVFF) is currently trading at $0.98, 22% below its 52-week high. It does not currently pay a regular dividend.
Nuvo Pharmaceuticals Inc. (MRVFF) is a healthcare stock trading at $0.98. It does not currently pay a regular dividend in our data, so it produces no dividend income and DRIP reinvestment does not apply. Investors seeking income often look at dividend ETFs such as SCHD, VYM or JEPI instead.
Auto-generated from live market data. For educational purposes only — not financial advice.
If DividendFlow helped you see your future dividend income clearly, other investors deserve the same clarity. Your review takes 30 seconds and makes a real difference.
⏱️ Takes 30 seconds · No signup · Free forever